Prostate Cancer
More than 90 percent of all prostate cancers are discovered while they are either localized (confined to the prostate) or regional (nearby). The five-year survival rate for men diagnosed with prostate tumors discovered at these stages is 99 percent.
In the past 20 years, the five-year survival rate for all stages combined has increased from 67 percent to 99 percent.
Early prostate cancer may not present any symptoms and can only be found with regular prostate examinations by your physician. Do not let fear and anxiety keep you from having the tests you need. These tests can often detect, or help rule out, prostate cancer.
Follow-up visits with your physician are extremely important if you have had an unusual DRE (digital rectal exam), or if your PSA (prostate-specific antigen) level is high. Your physician may order additional tests or suggest repeating the PSA tests.
Listed in the directory below you will find some additional information regarding prostate cancer, for which we have provided a brief overview.
Signs and Symptoms of Prostate Cancer
What are the symptoms of prostate cancer?
There are usually no specific signs or symptoms of early prostate cancer - which is why prostate screening is so important. An annual physical examination, prostate-specific antigen (PSA) blood test, and digital rectal exam (DRE) provide the best chance of identifying prostate cancer in its earliest stages.
The following are the most common symptoms of prostate cancer. However, each individual may experience symptoms differently. Symptoms may include:
- weak or interrupted flow of urine
- urinating often (especially at night)
- difficulty urinating or holding back urine
- inability to urinate
- pain or burning when urinating
- blood in the urine or semen
- nagging pain in the back, hips, or pelvis
- difficulty having an erection
The symptoms of prostate cancer may resemble other conditions or medical problems. Always consult your physician for a diagnosis.
As a man gets older, his prostate may grow bigger and obstruct the flow of urine, or interfere with sexual function. An enlarged prostate gland - a condition called benign prostatic hyperplasia - may require treatment with medicine or surgery to relieve symptoms. This common benign prostate condition, which is not cancer, can cause many of the same symptoms as prostate cancer.
Prostate Cancer Statistics
These statistics are from information published by the Surveillance, Epidemiology, and End Results (SEER) Program, a continuing project of the National Cancer Institute (NCI).
The SEER Program collects cancer data on a routine basis from designated population-based cancer registries in various areas of the country. Trends in cancer incidence, mortality and patient survival in the United States, as well as many other studies, are derived from this data bank.
Goals of the SEER Program include:
> Assembling and reporting, on a periodic basis, estimates of cancer incidence and mortality in the United States.
> Monitoring annual cancer incidence trends to identify unusual changes in specific forms of cancer occurring in population subgroups defined by geographic, demographic, and social characteristics.
> Providing continuing information on changes over time in the extent of disease at diagnosis, trends in therapy, and associated changes in patient survival.
> Promoting studies designed to identify factors amenable to cancer control interventions, such as:
a) environmental, occupational, socioeconomic, dietary, and health-related exposures
b) screening practices, early detection, and treatment
c) determinants of the length and quality of patient survival
Statistics on prostate cancer:
Consider the following statistics related to prostate cancer:
- Prostate cancer is the most common cancer among men, excluding skin cancer.
- American Cancer Society (ACS) estimates for 2007 include 218,890 new cases of prostate cancer in the US.
- Year 2007 estimates include 27,050 deaths occurring from prostate cancer in the US alone, making it the second leading cause of cancer death in men.
- All men are at risk for prostate cancer. The risk increases with age, and family history also increases the risk.
- African-American men have about a 60 percent higher incidence rate of prostate cancer than Caucasian men, and nearly a two-fold higher mortality rate than Caucasian men.
Risk Factors for Prostate Cancer
What is a risk factor?
A risk factor is anything that may increase a person's chance of developing a disease. It may be an activity, such as smoking, diet, family history, or many other things. Different diseases, including cancers, have different risk factors.
Although these factors can increase a person's risk, they do not necessarily cause the disease. Some people with one or more risk factors never develop cancer, while others develop cancer and have no known risk factors.
Knowing your risk factors to any disease can help to guide you into the appropriate actions, including changing behaviors and being clinically monitored for the disease.
What are risk factors for prostate cancer?
In general, all men are at risk for prostate cancer. However, there are specific risk factors that increase the likelihood that certain men will develop the disease, including the following:
- age
Age is a risk factor for prostate cancer, especially men age 50 and older. More than 70 percent of all prostate cancers are diagnosed in men over the age of 65. - race
Prostate cancer is nearly 60 percent more common among African-American men than it is among Caucasian-American men. Japanese and Chinese men native to their country have the lowest rates of prostate cancer. Interestingly, when Chinese and Japanese men immigrate to the US, they have an increased risk and mortality rate from prostate cancer, when compared to their native populations. In Japan, the incidence of prostate cancer has increased as Western diets and lifestyles have been adopted. - diet
Epidemiological data suggests that the diet consumed in Western industrialized countries may be one of the most important contributory factors for developing prostate cancer. Consider the following information regarding diet and its effect on the risk for prostate cancer:- fat
Studies suggest that men who eat a high-fat diet may have a greater chance of developing prostate cancer. - fiber
Dietary fiber intake may influence circulating levels of testosterone and estradiol, which, in turn, may decrease the progression of prostate cancer. - soy protein
Besides lower fat intake, another major difference between Asian and American diets is the consumption of soy, averaging 35 g a day per capita. Soy contains isoflavones which, in several studies, have been found to inhibit the growth of prostate cancer. - vitamin E and selenium
Vitamin E, an antioxidant, combined with selenium, has been shown to inhibit tumor growth in laboratory animals. - carotenoids
Carotenoids containing lycopenes have been shown to inhibit the growth of human prostate cancer cells in tissue cultures (cells grown in the laboratory). The primary source of lycopenes is processed tomatoes in tomato juice and tomato paste. - herbal preparations
Combination herbal preparations should be used with caution as reported side effects have included venous thrombosis, breast tenderness, and loss of libido. Many herbal preparations have not been studied in men with prostate cancer.
- fat
- obesity
Obesity not only contributes to diabetes and high cholesterol, but has also been associated with some common cancers, including hormone-dependent tumors such as prostate, breast, and ovarian cancer. - environmental exposures
Some studies show an increased chance for prostate cancer in men who are farmers, or those exposed to the metal cadmium while making batteries, welding, or electroplating. Additional research is needed in this area to confirm whether this is a true association. - having a vasectomy, BPH (benign prostatic hyperplasia), or STD (sexually transmitted disease)
Researchers have looked at whether men who have had a vasectomy, BPH, or those who have been exposed to a sexually transmitted disease are at increased risk for prostate cancer. Some studies suggest a link, while others do not support these claims. - family history of prostate cancer
Having a father or brother with prostate cancer more than doubles or triples a man's risk of developing this disease. The risk is even higher for men with several affected relatives, particularly if the relatives were young at the time of diagnosis. Geneticists (physicians and scientists who study inheritance and the causes of genetic disease) divide families into three groups, depending upon the number of men with prostate cancer and their ages of onset, including the following:- sporadic - a family with prostate cancer present in one man, at a typical age of onset; sporadic means ‘occurs by chance.'
- familial - a family with prostate cancer present in more than one person, but with no definitive pattern of inheritance and usually an older age of onset.
- hereditary - a family with a cluster of three or more affected relatives within any nuclear family (parents and their children), a family with prostate cancer in each of three generations on either the mother or father's side, or a cluster of two relatives affected at a young age (55 or less). Five to 10 percent of prostate cancer cases are considered hereditary.
- genetic factors
In the center of each cell of the human body, our genetic material - chromosomes - are found. Normally, cells contain 46 chromosomes, or 23 pairs, half of which are inherited from our mother, half from our father. The chromosomes contain the body's blueprint, our genes. Genes code for traits such as eye color and blood type, and also control important regulatory functions in the body such as the rate of cell growth. Some genes, when altered or mutated, give a higher risk for uncontrolled cell growth, which, in turn, can lead to tumor development. These genes have various names, but overall are referred to as "cancer susceptibility genes." Approximately 5 percent to 10 percent of all prostate cancers are known to be attributed to an inherited DNA change, such as the cancer susceptibility gene. Recent research points to findings that suggest there is a set of common DNA variations that lead to a higher risk of inherited prostate cancer in African American men and less than half that percentage in Caucasian men.
Staging of Prostate Cancer
What is staging of prostate cancer?
When prostate cancer is diagnosed, tests will be performed to determine how much cancer is present, and if the cancer has spread from the prostate to other parts of the body. This is called staging, and is an important step toward planning a treatment program.
What are the different stages of prostate cancer?
As defined by the National Cancer Institute (NCI), the stages of prostate cancer include the following:
| Stage I |
|
|---|---|
| Stage II |
|
| Stage III |
|
| Stage IV |
|
| Recurrent |
|
Grading of Prostate Cancer
What is grading of prostate cancer?
Another step in the diagnostic process is grading the cancer cells - taking a measurement of how fast the tumor is likely to grow and spread. Grading is done in the laboratory with cells taken from the prostate gland during biopsy. The cancer cells are measured by how closely they look like normal cells.
What is the Gleason System for grading cancer?
According to the National Comprehensive Cancer Network (NCCN), one way of grading prostate cancer is the Gleason System. This grading system is based on a number range from 2 to 10. The lower the number, the lower the grade, and the slower the cancer is growing. The higher the score, the higher the grade of the tumor. High-grade tumors grow more quickly than low-grade tumors, and are more likely to spread to other parts of the body.
- Grades under 6 mean that the cancer cells look similar to your normal cells, and the cancer is likely to be less aggressive.
- Grade 7 is in the intermediate range. This means that the cancer cells do not look like normal cells, and are more likely to be aggressive and grow faster.
- Grades 8 to 10 indicate that the cancer cells are more likely to be very aggressive in growth.
Diagnostic and Evaluation Procedures
Procedures used to evaluate prostate problems:
In addition to an annual physical examination that includes blood, urine, and possibly other laboratory tests, the National Cancer Institute and the American Cancer Society suggest consulting your physician about these recommendations for the evaluation of the prostate gland:
- DRE (digital rectal examinations)
As recommended by your physician, DREs are usually conducted annually for men over the age of 50. Men in high-risk groups, such as African-Americans, or those with a strong family history of prostate cancer should consult their physicians about being tested at a younger age. - PSA (prostate-specific antigen)
PSA is a blood test that measures the level of prostate specific antigen. PSA is a substance produced by the prostate gland, which may be found in higher amounts in men who have prostate cancer. As recommended by your physician, the PSA test is usually done annually for men over the age of 50. Men in high-risk groups, such as African-Americans, or those with a strong family history of prostate cancer, should consult their physicians about being tested at a younger age or more often.
What are some other prostate cancer evaluation procedures?
If the DRE or PSA are unusual, your physician may repeat the tests or request an ultrasound and other procedures. These evaluation tools may include:
- transrectal ultrasound (TRUS) - a test using sound wave echoes to create an image of the prostate gland to visually inspect for abnormal conditions such as gland enlargement, nodules, penetration of tumor through capsule of the gland, and/or invasion of seminal vesicles; may also be used for guidance of needle biopsies of the prostate gland and/or guiding the nitrogen probes in cryosurgery.
- computed tomography scan (Also called a CT or CAT scan.) - a diagnostic imaging procedure that uses a combination of x-rays and computer technology to produce cross-sectional images (often called slices), both horizontally and vertically, of the body. A CT scan shows detailed images of any part of the body, including the bones, muscles, fat, and organs. CT scans are more detailed than general x-rays.
- magnetic resonance imaging (MRI) - a diagnostic procedure that uses a combination of large magnets, radiofrequencies, and a computer to produce detailed images of organs and structures within the body.
- radionuclide bone scan - a nuclear imaging method that helps to show whether the cancer has spread from the prostate gland to the bones. The procedure involves an injection of radioactive material that helps to locate diseased bone cells throughout the entire body, suggesting possible metastatic cancer.
- lymph node and/or prostate biopsy - a procedure in which tissue samples are removed (with a needle or during surgery) from the body for examination under a microscope; to determine if cancer or other abnormal cells are present.
The diagnosis of cancer is confirmed only by a biopsy.
Treatments for Prostate Cancer
There are many different treatments for prostate cancer that involve the clinical care of a physician or other healthcare professional- Expectant Therapy
- Surgery
- Radiation Therapy
- Hormone Therapy
- Chemotherapy
- Angiogenesis Inhibitors
- Herbal Remedies
- Clinical Trials

